Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
1044.7500
1.15
(
0.11
%)
NSE
Sep 12, 2025
15:31 PM
31.42% Gain from 52W Low
Volume:
559.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
15 Nov 2019
1044.75
0.11%
Cadila Healthcare: Pharmaceuticals
Buy:
Zydus Lifesciences Ltd.
by
Karvy
Target: 274
Recommendation
Target
Karvy
Domestic formulations and US generics showing improved traction.
Geojit BNP Paribas increased Buy price target of Zydus Lifesciences Ltd. to 1121.0 on 03 Sep, 2025.
More from Zydus Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - September 12, 2025
The Baseline |
12 Sep 2025
Market closes higher, Hindustan Copper announces a Rs 2,000 crore capex
Trendlyne Marketwatch |
12 Sep 2025
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020, 01:51PM